Locapharm has successfully sold its home healthcare division, PSAD, to Santé Cie Group, focusing on core business growth and positioning in the thriving French home healthcare market.

Target Information

Locapharm, formerly known as Alcura France, is a wholly-owned subsidiary of Mutares SE & Co. KGaA (ISIN: DE000A2NB650). The company has recently completed the sale of its home healthcare activities, known as PSAD (Prestations de Santé à Domicile), to Santé Cie Group. This strategic move aims to streamline operations and focus on core business areas.

Under the leadership of a newly appointed management team, Locapharm has taken decisive steps to detach itself from its previous owner, Alliance Healthcare. This initiative includes rebranding under the historical name Locapharm and emphasizing its primary services in the Maintien à Domicile (MAD) sector. The company is also on a growth trajectory, having announced two acquisitions that will enhance its capabilities.

Industry Overview

The home healthcare industry in France has experienced significant growth in recent years, driven by an aging population and increasing demand for personalized care solutions. As healthcar